ScanXNewsLexaria begins dosing in GLP-1 study, receives patent Lexaria advances oral dosing study for next-gen GLP-1 drugs 1 min read Updated on 09 Jun 2026, 07:51 PM Reviewed by Anirudha BScanX News Team AI Summary Lexaria Bioscience Corp
They can provide specific tips tailored to your needs
It occurs in 2030% of patients within 1020 minutes of injection and resolves spontaneously within 3045 minutes
Semaglutide may contribute to modest reductions in blood pressure in some individuals, particularly when weight loss occurs
The following antibodies were used: anti-insulin (SigmaAldrich, #I2018, 1:400), anti-insulin (Boster, #BM0080, 1:100), anti-C-peptide (DSHB, #GN-ID4-S, 1:50), anti-C-peptide (Cell Signaling Technology, 4593S, 1:200), anti-ZnT8 (Thermo Fisher Scientific, #PA5-103252, 1:400), anti-ZnT8 (Lifespan Biosciences, #LS-C296473, 1:400), anti-Glucagon (Cell Signaling Technology, #2760S, 1:100), anti-ARX (R&D Systems, #AF-7068-SP, 1:50), anti-NKX6.1 (DSHB, #F55A12-c, 1:50), anti-GFP (MilliporeSigma, #06-896, 1:500), anti-mCherry (Abcam, #ab125096, 1:500), anti-CXCR4-PE (Thermo Fisher Scientific, #MHCXCR404, 1:100), anti-CD117-APC (Thermo Fisher Scientific, #CD11705, 1:100), anti-PDX1 (R&D Systems, #AF2419, 1:100), anti-somatostatin (Santa Cruz Biotechnology, #sc-7819, 1:100), anti-ATF4 (Proteintech, #10835-1-AP, 1:1000), anti-PERK (Cell Signaling Technology, #3192S, 1:1000), anti-p-PERK (ABclonal, #AP1501, 1:1000), anti-eIF2 (Beyotime, #AF6771, 1:1000), anti-p-eIF2 (Beyotime, #AF1237, 1:1000), anti--actin (Beyotime, #AF5001, 1:5000), anti-GAPDH (Beyotime, #AF1186, 1:5000), antibodies conjugated with Alexa Fluor 488 (715-545-150, 711-545-152, 712-545-150, 703-545-155, 1:500), Alexa Fluor 594 (715-585-150, 711-585-152, 712-585-153, 1:500), and Alexa Fluor 647 (715-605-151, 711-605-152, 712-605-153, 705-605-003, 713-605-147, 1:500) from Jackson ImmunoResearch, anti-mouse IgG HRP-linked antibody (Cell Signaling Technology, #7076P2, 1:10,000), and anti-rabbit IgG HRP-linked antibody (Cell Signaling Technology, #7074S, 1:10,000)
When using a GLP-1, maintaining muscle mass isn't just about cutting calories - its about hitting your daily protein targets
